Skip to main content

Schrodinger, Inc.

corporate_fare Company Profile

Schrodinger, Inc.

SDGR·NASDAQ·Life Sciences·CIK 0001490978

Schrodinger, Inc. transforms how therapeutics and materials are discovered using a differentiated, physics-based computational platform. This platform enables the discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at a lower cost compared to traditional methods. The company's software platform is licensed globally by biopharmaceutical and industrial companies, academic institutions, and government laboratories. Schrodinger applies its computational platform to advance a broad pipeline of drug discovery programs in collaboration with leading biopharmaceutical companies. Additionally, it uses its platform to discover novel molecules for its own pipeline of proprietary drug discovery programs, which are advanced through preclinical and clinical development. Traditional drug discovery is complex, lengthy, capital-intensive, and has high failure rates, relying on many iterations of costly and time-consuming manual molecule design, chemical synthesis, and experimental testing. Schrodinger's physics-based computational platform predicts critical properties of molecules with high accuracy, allowing drug discovery teams to design and selectively synthesize molecules with more optimal properties. This reduces the average time and costs to identify a development candidate and increases the probability of a program entering clinical development. The company believes development candidates with optimized property profiles have a higher probability of success in clinical development. Since the underlying physics for drug molecules and materials is the same, Schrodinger has extended its computational platform to materials science applications in fields such as aerospace, energy, semiconductors, electronic displays, and chemicals. The company offers various software solutions that accelerate all stages of molecule discovery, design, and optimization for its customers.

Schrodinger, Inc. (NASDAQ:SDGR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for SDGR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for SDGR spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Novartis Deal Reworked With $1.42B Milestone Potential as Q3 Revenue Tops Estimates
  • Schrödinger 10-Q: Q3 Revenue Up 19% to $64.5M, $373M Cash, Novartis Deal Amended
  • Schrödinger Lifts 2026 ACV and Drug Discovery Guidance as Q3 Revenue Grows 19%
  • Schrödinger Beats on Revenue Growth, Raises Full-Year ACV and Drug Discovery Outlook
  • Schrödinger Co-Founds Tectora with $55M Series A, Contributes Two Immunology Programs

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$255.87M
Net Income
-$103.27M
Diluted EPS
-$1.41
Op. Cash Flow
$13.9M
Free Cash Flow
$12.46M
Gross Profit
$142.61M
Operating Income
-$166.9M
Cash & Equivalents
$230.52M
Debt / Equity
0.00×
Net Margin
-40.4%
Shares Outstanding
73.44M sh
Source: 10-K · filed 2026-02-25 · accession 0001490978-26-000010

Short Interest & Short Volume

5.82 days to cover

FINRA reported short interest of 9,750,213 shares in SDGR as of the October 30, 2026 settlement, a 6.3% decrease from the prior period — about 5.8 days to cover at its recent average daily volume. On November 20, 2026, 35.6% of SDGR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)9,750,213 shares as of October 30, 2026
Change vs prior period▼ 6.3%
Days to cover5.82 at avg daily volume of 1,674,261
Daily short volume (FINRA facilities)35.6% of 705,626 shares on November 20, 2026
5-day average short volume53.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$23.25 +1.40% today
52-week range · as of 2026-11-04 $10.95 – $33.78
Market cap
$1.72B
Volume
1.9M (1.1× avg)
3-mo avg 1.7M
Live data · 2026-11-21 05:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SDGR - Latest Insights

SDGR
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.50
Real-time Price: $23.25 info
Change: -$6.25 (-21%) info
Market Cap: $1.722B info
SDGR
Nov 04, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.44
Real-time Price: $23.25 info
Change: -$8.19 (-26%) info
Market Cap: $1.722B info
SDGR
Nov 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.75
Real-time Price: $23.25 info
Change: -$7.50 (-24%) info
Market Cap: $1.722B info
SDGR
Nov 04, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $28.72
Real-time Price: $23.25 info
Change: -$5.47 (-19%) info
Market Cap: $1.722B info
SDGR
Sep 09, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $20.03
Real-time Price: $23.25 info
Change: +$3.22 (+16%) info
Market Cap: $1.722B info
SDGR
Aug 05, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $15.71
Real-time Price: $23.25 info
Change: +$7.54 (+48%) info
Market Cap: $1.722B info
SDGR
Jun 29, 2026, 4:33 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $17.39
Real-time Price: $23.25 info
Change: +$5.86 (+34%) info
Market Cap: $1.722B info
SDGR
Jun 29, 2026, 4:29 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.39
Real-time Price: $23.25 info
Change: +$5.86 (+34%) info
Market Cap: $1.722B info
SDGR
Jun 23, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.04
Real-time Price: $23.25 info
Change: +$8.21 (+55%) info
Market Cap: $1.722B info
SDGR
May 05, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $11.70
Real-time Price: $23.25 info
Change: +$11.55 (+99%) info
Market Cap: $1.722B info
SDGR
May 05, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.70
Real-time Price: $23.25 info
Change: +$11.55 (+99%) info
Market Cap: $1.722B info
SDGR
May 05, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $11.98
Real-time Price: $23.25 info
Change: +$11.27 (+94%) info
Market Cap: $1.722B info
SDGR
Apr 28, 2026, 7:50 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $11.51
Real-time Price: $23.25 info
Change: +$11.74 (+102%) info
Market Cap: $1.722B info
SDGR
Feb 25, 2026, 4:11 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $11.78
Real-time Price: $23.25 info
Change: +$11.47 (+97%) info
Market Cap: $1.722B info
SDGR
Feb 25, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.90
Real-time Price: $23.25 info
Change: +$11.35 (+95%) info
Market Cap: $1.722B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets